NM_005677.4:c.167C>T
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 3P and 11B. PM1PP2BP4_ModerateBP6BS1BS2
The NM_005677.4(COLQ):c.167C>T(p.Pro56Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000173 in 1,614,104 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P56P) has been classified as Likely benign.
Frequency
Consequence
NM_005677.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 5Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COLQ | NM_005677.4 | c.167C>T | p.Pro56Leu | missense_variant | Exon 2 of 17 | ENST00000383788.10 | NP_005668.2 | |
| COLQ | NM_080538.2 | c.137C>T | p.Pro46Leu | missense_variant | Exon 2 of 17 | NP_536799.1 | ||
| COLQ | NM_080539.4 | c.167C>T | p.Pro56Leu | missense_variant | Exon 2 of 16 | NP_536800.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000466 AC: 71AN: 152212Hom.: 1 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000215 AC: 54AN: 251426 AF XY: 0.000162 show subpopulations
GnomAD4 exome AF: 0.000142 AC: 208AN: 1461892Hom.: 2 Cov.: 31 AF XY: 0.000133 AC XY: 97AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000466 AC: 71AN: 152212Hom.: 1 Cov.: 33 AF XY: 0.000632 AC XY: 47AN XY: 74360 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 5 Uncertain:1Benign:1
- -
- -
Inborn genetic diseases Uncertain:1
The c.167C>T (p.P56L) alteration is located in exon 2 (coding exon 2) of the COLQ gene. This alteration results from a C to T substitution at nucleotide position 167, causing the proline (P) at amino acid position 56 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at